| 引用本文： |
-
杨传家,宫建,吴锋,王国锋,许维雪,刘臻,崔东旭.乙酰肝素酶与甲状腺乳头状癌淋巴结转移的相关性研究[J].广西科学,2015,22(1):44-47. [点击复制]
- YANG Chuan-jia,GONG Jian,WU Feng,WANG Guo-feng,XU Wei-xue,LIU Zhen,CUI Dong-xu.Effect of Heparanase on Lymphatic Metastasis of Papillary Thyroid Neoplasms[J].Guangxi Sciences,2015,22(1):44-47. [点击复制]
|
|
| |
|
|
| 本文已被：浏览 463次 下载 503次 |
码上扫一扫！ |
| 乙酰肝素酶与甲状腺乳头状癌淋巴结转移的相关性研究 |
|
杨传家1, 宫建2, 吴锋3, 王国锋4, 许维雪1, 刘臻1, 崔东旭1
|
|
|
| (1.中国医科大学附属盛京医院胰腺甲状腺外科, 辽宁沈阳 110004;2.沈阳药科大学生命科学与生物制药学院临床药学教研室, 辽宁沈阳 110016;3.大连市第六人民医院ICU科, 辽宁大连 116000;4.中国医科大学附属第四医院心内科, 辽宁沈阳 110004) |
|
| 摘要: |
| [目的]通过研究乙酰肝素酶(HPA)含量与微淋巴管密度的关系,探讨HPA在甲状腺乳头状癌淋巴结转移中的作用。[方法]采用Envision免疫组织化学两步法检测150例甲状腺乳头状癌和200例结节性甲状腺肿患者乙酰肝素酶、D2-40的表达情况,计算乙酰肝素酶平均光密度值与D2-40阳性标记的微淋巴管密度,分析乙酰肝素酶含量与微淋巴管密度间的关系,同时与结节性甲状腺肿患者微淋巴管密度和乙酰肝素酶含量分别进行比较。[结果]甲状腺乳头状癌患者微淋巴管密度和乙酰肝素酶含量明显高于结节性甲状腺肿患者(P<0.01),癌组织乙酰肝素酶含量与微淋巴管密度呈正相关关系(P<0.01)。[结论]甲状腺乳头状癌患者乙酰肝素酶与微淋巴管形成有密切关系,乙酰肝素酶可作为其临床疗效判断和新药研发的参考指标。 |
| 关键词: 甲状腺癌 淋巴结转移 微淋巴管 乙酰肝素酶 |
| DOI：10.13656/j.cnki.gxkx.20140610.002 |
| 投稿时间：2014-05-12修订日期：2014-05-18 |
| 基金项目:中国医大盛京医院科学研究基金项目(M996)和国家自然科学基金项目(81072182)资助。 |
|
| Effect of Heparanase on Lymphatic Metastasis of Papillary Thyroid Neoplasms |
|
YANG Chuan-jia1, GONG Jian2, WU Feng3, WANG Guo-feng4, XU Wei-xue1, LIU Zhen1, CUI Dong-xu1
|
| (1.Department of Pancreatic and Thyroid, Shengjing Hospital, China Medical University, Shenyang, Liaoning, 110004, China;2.Department of Clinical Pharmacy, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China;3.Intensive Care Unit, Sixth Hospital of Dalian, Dalian, Liaoning, 116000, China;4.Department of Cardiology, the Fourth Hospital, China Medical University, Shenyang, Liaoning, 110004, China) |
| Abstract: |
| [Objective] By studying the relationship between heparanase (HPA) content and micro-lymphatic vessel density, we investigated the effect of heparanase on lymphatic metastasis of papillary thyroid cancer.[Methods] Heparanase and D2-40 levels were detected in 150 specimens of papillary thyroid cancer and 200 of nodular goiter by Envision immunohistochemistry.Micro-lymphatic vessels were identified immunohistochemically as D2-40-positive.The relationship between micro-lymphatic vessel density and heparanase levels was analyzed.[Results] Micro-lymphatic vessel density and heparanase levels in patients with papillary thyroid cancer were significantly higher than those in nodular goiter patients (P<0.01).The content of heparanase was positively related with the micro-lymphatic vessel density in tumor tissues (P<0.01).[Conclusion] The metastasis process of papillary thyroid cancer is associated with heparanase levels.Heparanase may be a potential marker on the therapeutic effect and new drugs for papillary thyroid cancer in the future. |
| Key words: thyroid carcinoma lymph node metastasis micro-lymphatic vessel heparanase |
|
|
|
|
|
